Inderjeet Kaur Selected Research

Inderjeet Kaur Research Topics

Disease

13	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2010 - 01/2002
8	Inflammation (Inflammations) 04/2024 - 01/2014
7	Macular Degeneration (Age-Related Maculopathy) 01/2019 - 09/2006
6	Diabetic Retinopathy (Retinopathy, Diabetic) 04/2024 - 01/2019
5	Hypoxia (Hypoxemia) 01/2023 - 01/2019
4	Malaria 11/2021 - 03/2015
3	Aspergillosis 01/2023 - 01/2022
3	Vascular Diseases (Vascular Disease) 01/2023 - 01/2019
3	Glaucoma 01/2021 - 01/2009
3	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2021 - 01/2019
3	Infections 01/2020 - 10/2015
2	Mucormycosis 01/2023 - 01/2023
2	Neoplasms (Cancer) 01/2023 - 04/2016
2	Carcinoma (Carcinomatosis) 01/2021 - 01/2018
2	Cataract (Cataracts) 01/2019 - 01/2017
2	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2019 - 10/2010
2	Virus Diseases (Viral Diseases) 01/2017 - 07/2016
2	Dengue (Dengue Fever) 07/2016 - 10/2015
2	Lepromatous Leprosy 06/2005 - 06/2005
2	Multibacillary Leprosy 06/2005 - 09/2002
1	Macular Edema 04/2024
1	Hyperglycemia 01/2024
1	Eye Diseases (Eye Disease) 07/2023
1	Sudden Infant Death (SID) 05/2023
1	Retinal Neovascularization 02/2023
1	Myopia 01/2023
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2023
1	Congenital Abnormalities (Deformity) 01/2023
1	COVID-19 01/2023
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Shock 01/2023
1	Uveitis 01/2023
1	Posterior Uveitis 01/2023
1	Carcinogenesis 01/2023
1	Keratitis 06/2021
1	Choroidal Neovascularization 01/2021
1	Weight Gain 01/2021

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 04/2024 - 03/2015
7	Retinaldehyde (Retinal)IBA 01/2024 - 01/2019
6	MicroRNAs (MicroRNA)IBA 02/2023 - 10/2015
6	Complement System Proteins (Complement)IBA 01/2023 - 01/2010
5	Methotrexate (Mexate)FDA LinkGeneric 03/2008 - 07/2002
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 11/2007
3	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2021
3	Messenger RNA (mRNA)IBA 01/2024 - 10/2015
3	CalciumIBA 01/2023 - 01/2019
3	Complement Factor B (Factor B)IBA 01/2023 - 01/2010
3	Volatile Oils (Essential Oils)IBA 01/2023 - 01/2022
3	RNA (Ribonucleic Acid)IBA 01/2021 - 10/2015
3	ProteomeIBA 01/2020 - 01/2017
3	Transcription Factors (Transcription Factor)IBA 07/2014 - 01/2009
3	calcipotriene (calcipotriol)FDA LinkGeneric 07/2010 - 10/2003
3	Anthralin (Dithranol)IBA 07/2010 - 08/2002
2	EnzymesIBA 01/2023 - 01/2023
2	Collagen Type XVIII (Type XVIII Collagen)IBA 01/2023 - 07/2014
2	artemisinin (artemisinine)IBA 11/2021 - 07/2020
2	CytokinesIBA 01/2020 - 01/2017
2	Coal Tar (Estar)IBA 07/2010 - 10/2003
2	Acitretin FDA Link 04/2009 - 08/2002
2	VaccinesIBA 06/2005 - 09/2002
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2004 - 06/2003
1	AntioxidantsIBA 01/2024
1	methylxanthineIBA 01/2023
1	Investigational DrugsIBA 01/2023
1	geraniol (nerol)IBA 01/2023
1	discoidin-binding polysaccharideIBA 01/2023
1	3,4-dihydroxy-2-butanoneIBA 01/2023
1	human ERBB2 proteinIBA 01/2023
1	ResveratrolIBA 01/2023
1	EucalyptolIBA 01/2023
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2023
1	Capsules (Microcapsules)IBA 01/2023
1	Chitin SynthaseIBA 01/2023
1	Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing)IBA 01/2023
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2023
1	Riboflavin (Vitamin B2)FDA LinkGeneric 01/2023
1	Riboflavin SynthaseIBA 01/2023
1	Superoxides (Superoxide)IBA 01/2023
1	Uridine Diphosphate (UDP)IBA 01/2023
1	Uridine Diphosphate Glucose (UDP Glucose)IBA 01/2023
1	GlycosyltransferasesIBA 01/2023
1	Protein Isoforms (Isoforms)IBA 01/2023
1	Moclobemide (Arima)IBA 01/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2023
1	Toll-Like Receptors (Toll-Like Receptor)IBA 06/2021
1	Edetic Acid (EDTA)FDA Link 01/2021
1	Doxycycline (Periostat)FDA LinkGeneric 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Long Noncoding RNAIBA 01/2021
1	ThrombospondinsIBA 01/2021
1	Matrix Metalloproteinases (MMPs)IBA 01/2021
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2021

Therapy/Procedure

10	Therapeutics 05/2023 - 07/2002
2	Drug Therapy (Chemotherapy) 01/2018 - 10/2004
2	Immunotherapy 06/2005 - 06/2005
1	Oral Administration 01/2023
1	Lasers (Laser) 01/2023
1	Brachytherapy 01/2021
1	Chemoradiotherapy 01/2021